CDKN2A and neoplasm: Our TCGA database analysis shows that tumors were significantly overexpressed microbial homologous proteins in common (For example MMP9, CDKN2A, MYBL2)9, which probably plays as tumor antigens provoking anti-tumor immunity and targets for chimeric antigen receptor T cell immunotherapy (Car-T therapy).